All Proteomics & Enzymology articles
-
NewsResearchers enable microorganisms to build molecules with light
Researchers are continually looking for new ways to hack the cellular machinery of microbes to make useful products. A new study shows they can expand the biosynthetic capabilities of these microbes by using light to help access new types of chemical transformations.
-
NewsResurrected ancient enzyme offers new window into early Earth and the search for life beyond it
By resurrecting a 3.2-billion-year-old enzyme and studying it inside living microbes, researchers have created a new way to improve our understanding of the origins of life on Earth. The study uses synthetic biology to reverse-engineer modern enzymes and rebuild their possible ancestors.
-
NewsScientists engineer quantum-enabled proteins, opening a new frontier in biotechnology
A new study reports the creation of a new class of biomolecules, magneto-sensitive fluorescent proteins, that can interact with magnetic fields and radio waves. This is enabled by quantum mechanical interactions within the protein, and occur when it is exposed to light of an appropriate wavelength.
-
NewsReconstructing nature’s oxindole factory: yeast-based biosynthesis of medicinal indole alkaloids
By identifying four key enzymes from a North American plant and reconstituting them in yeast, scientists have achieved complete de novo biosynthesis of complex oxindole molecules that are difficult to obtain from plants or chemical synthesis.
-
NewsScientists develop new biosynthetic route to optically pure S-2-Hydroxyisovalerate
By uncovering an unexpected enzyme activity and combining it with precise metabolic engineering, scientists has transformed Escherichia coli into a microbial factory capable of producing gram-per-liter levels of optically pure S-HIV from renewable carbon sources.
-
NewsWhat causes some people’s gut microbes to produce high alcohol levels?
A study of people with a rare condition known as auto-brewery syndrome has found a link between gut microbes and symptoms of intoxication, pointing to new treatment strategies.
-
NewsNew findings on Candida auris open up potential targets for future therapies
A study shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B.
-
NewsAn enzyme neutralizes pathogens by cleaving a bacterial toxin
Researchers have discovered an enzyme that neutralizes the virulence factor malleicyprol in the bacterium Burkholderia pseudomallei, considered one of the most dangerous bacterial pathogens in the tropics.
-
NewsBreakthrough AI speeds up discovery of life-supporting microbes
Scientists have developed a powerful new artificial intelligence tool called LA⁴SR that can rapidly identify previously overlooked proteins in microalgae - tiny organisms that produce much of the Earth’s oxygen and support entire aquatic ecosystems.
-
NewsFor certain life-essential proteins in E. coli, repair is more likely
A new study shows that E. coli proteins containing a specific structure are more likely to misfold and, if they are required the bacteria’s survival, more likely to be repaired.
-
NewsResearchers identify bacterial enzyme that can cause fatal heart conditions with pneumonia infections
Researchers have identified a bacterial enzyme that may be the reason some people get heart complications with pneumonia, while others do not. Since enzymes create chemical reactions to help bacteria survive, grow, and sometimes attack tissues, zmpB could become a target for future therapies.
-
NewsThe power of gut enzymes: why healthy eating affects everyone differently
Researchers have uncovered a mechanism that determines how our gut microbiome processes healthful plant compounds. The chemical cookbook of gut bacteria varies from person to person—and is often disrupted in chronic diseases.
-
NewsLight-sensitive microbial protein may herald new cancer therapies
Researchers used a mouse cancer model to show that tumors expressing Archaerhodopsin 3 shrink after exposure to green light.
-
NewsToxoplasmosis: How a deadly parasite infects its host cells
Researchers have discovered how the parasite Toxoplasma gondii builds a specialised structure that allows it to move and invade host cells. They identified two proteins that control how the conoid complex is assembled - this acts like an engine for movement and cell-invasion.
-
NewsScientist who harnesses bacteria to deliver green solutions is winner in 2025 Tata Transformation Prize
A scientist who harnesses bacteria to deliver green solutions has been named as one of the winners of the 2025 Tata Transformation Prize. Balasubramanian Gopal, PhD, Indian Institute of Science, has been named Sustainability Winner in the awards.
-
NewsHow life first got moving: nature’s motor from billions of years ago
Research has cast light on the evolutionary origins of one of nature’s first motors, which developed 3.5 billion to 4 billion years ago to propel bacteria. Scientists have created the most comprehensive picture yet of the evolution of bacterial stators.
-
NewsScientists unlock how viruses punch above their weight
A news study reveals how rabies virus manipulates so many cellular processes despite being armed with only a few proteins. Researchers believe other dangerous viruses like Nipah and Ebola may also work the same way.
-
NewsAncient viral DNA shapes modern human placentas
Researchers have uncovered how ancient viral DNA controls a gene linked to placenta development and pre-eclampsia, a life-threatening pregnancy disorder. The research could help identify pre-eclampsia risk much earlier.
-
NewsCARBIOS and Wankai New Materials to build PET biorecycling plant in China
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to the large-scale deployment of CARBIOS’ PET biorecycling technology in Asia, with the first step being the construction of a PET biorecycling plant in China.
-
NewsNew study finds targets for a new tuberculosis vaccine
A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.